October 2023

Update

CADDRA is an independent, non-profit association for health professionals in the medical and research sectors interested in ADHD.

October is ADHD Awareness Month

October is recognized as a time to promote education and understanding about Attention Deficit Hyperactivity Disorder.

This month, let us come together to support those with ADHD and advocate for greater understanding and resources for those affected by this disorder.

We will let the Pictures do the Talking

Research Day

Welcome Reception

Conference

Awards

Other Fun Stuff

Members & Speakers Dinner

Bagel Walk

Mind & body exercise

You're All Invited to Winnipeg in 2024!

11^th Annual ADHD Research Day

Friday, September 27^th

20^th Annual ADHD Conference

September 28-29th

WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents

Spearheaded by Samuele Cortese, MD, PhD, this important piece, avidly supported by CADDRA and many other associations, has been published in The Lancet Psychiatry.

A Request to Sign a Petition

Consider signing this petition requesting the Canadian Government to increase the budget for health research conducted by the Canadian Institutes of Health Research (CIHR).

A life with ADHD

A life with ADHD is a free online course for people affected by attention deficit disorder, their families, and the professionals who care for them. The course was developed by the University of Geneva in collaboration with international experts on ADHD.

Nova Scotia Pilot Program

A new pilot program to increase public access to assessment and diagnosis services for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and autism spectrum disorder (ASD) has been launched in Nova Scotia.

Current ADHD Research

Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study. Craig B. H. Surman, MD; Daniel M. Walsh, BA; Nora Horick, MS; Maura DiSalvo, MPH; Chloe Hutt Vater, BA; and Daniel Kaufman, BS. The Journal of Clinical Psychiatry (2023)

Prevalence and Trends in Diagnosed ADHD Among US Children and Adolescents, 2017-2022. Li, Yanmei, et al. JAMA Network Open 6.10 (2023): e2336872-e2336872.

Abuse, neglect and neurodevelopment across the life course: what can paediatricians and child psychiatrists do about this together? The Rees-Illingworth keynote lecture 2023. Minnis, Helen. Archives of Disease in Childhood (2023).

“I’m Doing Okay”: Strengths and Resilience of Children with and without ADHD. Charabin, Emma, et al. Journal of Attention Disorders 27.9 (2023): 1009-1019.

Assessments for adult ADHD: what makes them good enough?. Leaver, Laurence, et al. British Journal of General Practice 73.735 (2023): 473-474.

Not so smart? “Smart” drugs increase the level but decrease the quality of cognitive effort. Bowman, Elizabeth, et al. Science Advances 9.24 (2023): eadd4165.

Association between stimulant treatment and substance use through adolescence into early adulthood. Molina, Brooke SG, et al. JAMA psychiatry 80.9 (2023): 933-941.

Visit our booth at the following events:

Canadian Psychiatric Association Annual Conference

October 19-21, 2023

Vancouver, BC

Family Medicine Forum (FMF)

November 8-10, 2023

Montréal, QC

Available on ADHDLearn

Online Courses

CADDRA Introduction to ADHD for Healthcare Professionals (accredited program, free for members)
Introduction au TDAH de la CADDRA pour les professionnels de la santé (programme accrédité, gratuit pour les membres);
CADDRA Expert Series 2023 (accredited program, reduced fee for members)
ADHD in Practice (FREE accredited program)

Canadian ADHD Practice Guidelines (free access for members)

Are You Professionally Involved with ADHD?

Discover the benefits of becoming a member of CADDRA.

FIND OUT MORE